Background Childhood obesity is increasingly accompanied by metabolic dysfunction-associated steatotic liver disease (MASLD), creating a need for accessible screening strategies in routine clinical care. We aimed to develop and externally validate a machine learning (ML) model based on routinely available clinical data to identify ultrasound-defined MASLD in children with overweight or obesity. Methods In this retrospective multicenter study, overweight or obese children aged 5–16 years were identified from outpatient records at two hospitals. Anthropometric measurements, routine blood tests, and biochemical indicators were collected, and MASLD status was determined by abdominal ultrasound. A stacking ensemble model integrating ten ML algorithms was developed using routinely available clinical variables, and its performance was assessed by 10-fold cross-validation and external validation. Complementary feature-contribution analysis was performed using SHAP for the AdaBoost base classifier. Results A total of 7,454 children (3,475 events and 3,979 non-events) from Nanjing and 353 children (129 events and 224 non-events) from Suzhou were included. Using 46 clinical variables, the stacking ensemble model achieved an area under the receiver operating characteristic curve (AUC) of 0.877 from patient-level out-of-fold predictions in 10-fold cross-validation within the development set and 0.865 in the independent external validation set, indicating good discrimination. However, external validation showed overprediction of absolute risk, highlighting the need for further recalibration and validation in larger and more diverse populations. SHAP analysis of the AdaBoost base classifier identified liver enzymes and metabolic markers as major contributors to its predictions. A web-based application was further developed to demonstrate individualized model output. Conclusion This multicenter machine-learning model demonstrated good discrimination for identifying ultrasound-defined MASLD in children with overweight or obesity. Built on routinely available clinical variables, this model may support future identification of ultrasound-defined MASLD after further validation and recalibration.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: